The coordination core has 5 functions: 1. Provide structure and facilitate communication among the investigators in Projects 1 to 4. This communication will take place during weekly meetings with Individual Project Leaders and their staff, and quarterly meetings with the entire Program Project investigators. The purpose of these meetings is to apprise the investigators of the progress of the individual projects and to assess for problems that may occur in technical or organizational aspects of the work. 2. Patient recruitment. The Study Coordinator will be a member of the Administrative Core team and will work directly with the rheumatologists and nephrologists at The Ohio State University and in the collaborating Centers to assist them in identifying and enrolling study patients. 3. Distribution of patient samples obtained from Project 4 to each of the Project laboratories. The Study Coordinator, Working with the Research Assistant in Project 4, will ensure timely delivery of the blood and urine specimens, and under the proper preservation conditions. The initial separation of the blood samples, prior to their delivery to the individual Project laboratories, will also be accomplished by this group. 4. Data management and data analysis. This aspect of the Core function is under the direction of Dr. Nagaraja working in collaboration with Drs. Lin and Gassman. 5. Coordinate the Internal Review Committee's periodic evaluation of the progress of the Program Project. The Internal Review Committee consists of 5 distinguished scientists of The Ohio State University College of Medicine. Their identifies, special interests, and a role in the Program Project are described in Core. The Internal Review Committee should help maintain rigor and appropriate pace for the Program Project.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
5P01DK055546-02
Application #
6570869
Study Section
Special Emphasis Panel (ZDK1)
Project Start
2002-04-01
Project End
2003-03-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
2002
Total Cost
$295,892
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Birmingham, Daniel J; Merchant, Michael; Waikar, Sushrut S et al. (2017) Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise. Nephrol Dial Transplant 32:i71-i79
Lintner, Katherine E; Wu, Yee Ling; Yang, Yan et al. (2016) Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Front Immunol 7:36
Birmingham, Daniel J; Bitter, Joshua E; Ndukwe, Ezinne G et al. (2016) Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare. Clin J Am Soc Nephrol 11:47-53
Parikh, Samir V; Nagaraja, Haikady N; Hebert, Lee et al. (2014) Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis. Clin J Am Soc Nephrol 9:279-84
Birmingham, Daniel J; Shidham, Ganesh; Perna, Annalisa et al. (2014) Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease. Ann Rheum Dis 73:475-6
Freedman, Barry I; Langefeld, Carl D; Andringa, Kelly K et al. (2014) End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol 66:390-6
Hebert, Lee A; Parikh, Samir; Prosek, Jason et al. (2013) Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol 38:253-66
Young, Nicholas A; Friedman, Alexandra K; Kaffenberger, Benjamin et al. (2013) Novel estrogen target gene ZAS3 is overexpressed in systemic lupus erythematosus. Mol Immunol 54:23-31
Fukuda, Akihiro; Wickman, Larysa T; Venkatareddy, Madhusudan P et al. (2012) Urine podocin:nephrin mRNA ratio (PNR) as a podocyte stress biomarker. Nephrol Dial Transplant 27:4079-87
Birmingham, D J; Hebert, L A; Song, H et al. (2012) Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 21:855-64

Showing the most recent 10 out of 68 publications